APOBEC3A/B deletion polymorphism and endometrial cancer risk.
Nigar SofiyevaCamilla KrakstadMari K HalleTracy A O'MaraPål RomundstadKristian HveemLars VattenPer E LønningLiv B GansmoStian KnappskogPublished in: Cancer medicine (2022)
The APOBEC3A/B deletion polymorphism is associated with a decreased risk of endometrial cancer in the Norwegian population.
Keyphrases